[HTML][HTML] Maintenance chemotherapy for patients with rhabdomyosarcoma
G Bisogno, V Minard-Colin, M Jenney, A Ferrari… - Cancers, 2023 - mdpi.com
Simple Summary The updated results of the RMS2005 randomized study confirm that
patients with non-metastatic high risk rhabdomyosarcoma have an improved survival when …
patients with non-metastatic high risk rhabdomyosarcoma have an improved survival when …
[HTML][HTML] Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: A real-world study
Y Lan, L Wu, Y Hong, X Sun, J Wang… - Frontiers in …, 2023 - frontiersin.org
Introduction: Metronomic maintenance therapy (MMT) has significantly improved the survival
of patients with high-risk rhabdomyosarcoma in clinical trials. However, there remains a lack …
of patients with high-risk rhabdomyosarcoma in clinical trials. However, there remains a lack …
Chemotherapy in pediatric low-grade gliomas (PLGG)
A Lassaletta, M Zapotocky, E Bouffet - Child's Nervous System, 2024 - Springer
Pediatric low-grade gliomas (PLGG) are commonly treated with a combination of surgery,
radiotherapy, and chemotherapy. Recent trends prioritize reducing long-term morbidities …
radiotherapy, and chemotherapy. Recent trends prioritize reducing long-term morbidities …